SS-31 is a promising therapeutic peptide for addressing mitochondrial dysfunction oxidative stress and age related decline. its ability to stabilize cardiolipin restore mitochondrial cristae and prevent proton leak makes it a versatile candidate for treating a wide array of diseases, including metabolic, neurodegenerative and cardiovascular disorders.
